Literature DB >> 19794286

Adiponectin gene single-nucleotide polymorphisms and treatment response to obesity.

K Tsuzaki1, K Kotani, N Nagai, K Saiga, Y Sano, T Hamada, T Moritani, M Yoshimura, K Egawa, C Horikawa, Y Kitagawa, Y Kiso, N Sakane.   

Abstract

BACKGROUND: In the adiponectin gene polymorphisms, single-nucleotide polymorphism (SNP)-45 and SNP276 have reportedly been associated with obesity, Type 2 diabetes, and other features of metabolic syndrome. AIM: Whether these adiponectin SNP affect obesity-related parameters during caloric restriction in obese subjects. SUBJECTS AND METHODS: Thirty- two obese Japanese women were treated by meal replacement with a low calorie diet for 8 weeks and asked to maintain their habitual lifestyle. Obesity-related parameters were measured before and after the treatment period. We determined four SNP (T45G, I164T, G276T, and C-11377G) using a fluorescent allele-specific DNA primer assay systemand FRET probe assay system.
RESULTS: After the treatment, the extent of decrease in waist circumference was greater in the subjects with the G/G or G/T genotype of SNP276 than in those with the T/T genotype (p=0.026). As for SNP45, the extent of decrease in triglyceride levels was greater in the subjects with the T/T genotype than in those with the T/G genotype (p=0.003). For SNP-11377, the extent of decrease in systolic blood pressure and fasting plasma glucose was greater in the subjects with the C/G or G/G genotype than in those with the C/C genotype (p=0.044).
CONCLUSION: Our findings indicate that each SNP in the adiponectin gene might modify the change in obesity-related parameters during meal replacement with a low calorie diet.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19794286     DOI: 10.1007/BF03346474

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  32 in total

1.  Adiponectin I164T gene polymorphism and the obesity-related effects on the Japanese female population.

Authors:  Kazuhiko Kotani; Kyoko Saiga; Youichi Kurozawa; Naoki Sakane; Kokoro Tsuzaki; Taku Hamada
Journal:  Clin Chim Acta       Date:  2007-06-16       Impact factor: 3.786

2.  The angiotensin II type 2 receptor gene polymorphism and body mass index in healthy Japanese women.

Authors:  Kazuhiko Kotani; Naoki Sakane; Kyoko Saiga; Kokoro Tsuzaki; Yoshiko Sano; Haosheng Mu; Youichi Kurozawa
Journal:  Ann Clin Biochem       Date:  2007-01       Impact factor: 2.057

3.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

Review 4.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

Review 5.  Behavioral interventions for obesity.

Authors:  Laverne A Berkel; Walker S Carlos Poston; Rebecca S Reeves; John P Foreyt
Journal:  J Am Diet Assoc       Date:  2005-05

6.  Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin.

Authors:  W S Yang; W J Lee; T Funahashi; S Tanaka; Y Matsuzawa; C L Chao; C L Chen; T Y Tai; L M Chuang
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

7.  Genomic structure and mutations in adipose-specific gene, adiponectin.

Authors:  M Takahashi; Y Arita; K Yamagata; Y Matsukawa; K Okutomi; M Horie; I Shimomura; K Hotta; H Kuriyama; S Kihara; T Nakamura; S Yamashita; T Funahashi; Y Matsuzawa
Journal:  Int J Obes Relat Metab Disord       Date:  2000-07

8.  The -11377 C>G promoter variant of the adiponectin gene, prevalence of coronary atherosclerosis, and incidence of vascular events in men.

Authors:  Guenter Hoefle; Axel Muendlein; Christoph H Saely; Lorenz Risch; Philipp Rein; Lorena Koch; Fabian Schmid; Stefan Aczel; Thomas Marte; Peter Langer; Heinz Drexel
Journal:  Thromb Haemost       Date:  2007-03       Impact factor: 5.249

9.  Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma.

Authors:  Y Nakano; T Tobe; N H Choi-Miura; T Mazda; M Tomita
Journal:  J Biochem       Date:  1996-10       Impact factor: 3.387

10.  Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.

Authors:  M H Davidson; J Hauptman; M DiGirolamo; J P Foreyt; C H Halsted; D Heber; D C Heimburger; C P Lucas; D C Robbins; J Chung; S B Heymsfield
Journal:  JAMA       Date:  1999-01-20       Impact factor: 56.272

View more
  4 in total

1.  Analysis of adiponectin gene polymorphisms in Chinese population with systemic lupus erythematosus.

Authors:  Wen Liang Fang; Bin Zhou; Yan Yun Wang; Yu Chen; Lin Zhang
Journal:  J Biomed Biotechnol       Date:  2010-04-15

2.  Variations in Adipokine Genes AdipoQ, Lep, and LepR are Associated with Risk for Obesity-Related Metabolic Disease: The Modulatory Role of Gene-Nutrient Interactions.

Authors:  Jennifer Emily Enns; Carla G Taylor; Peter Zahradka
Journal:  J Obes       Date:  2011-04-19

3.  Association between carriers of the G allele of the + 45T> G variant of the ADIPOQ gene (rs 2241766) and the cardiometabolic profile in sickle cell trait.

Authors:  Jamila Benvegnú Bruno; Emanuelle Schneider Dal Ponte; Vanessa Retamoso; Patrícia Maurer; Lyana Feijoó Berro; Vanusa Manfredini; Jacqueline da Costa Escobar Piccoli
Journal:  Heliyon       Date:  2021-03-11

4.  ADIPOQ polymorphisms are associated with changes in obesity-related traits in response to aerobic training programme in women.

Authors:  Agata Leońska-Duniec; Anna Grzywacz; Zbigniew Jastrzębski; Aleksandra Jażdżewska; Ewelina Lulińska-Kuklik; Waldemar Moska; Katarzyna Leźnicka; Krzysztof Ficek; Agata Rzeszutko; Marcin Dornowski; Paweł Cięszczyk
Journal:  Biol Sport       Date:  2017-12-30       Impact factor: 2.806

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.